Table 4.
Event | JieDuTongLuoShengJin granules + HCQ (%) | Placebo + HCQ (%) |
---|---|---|
Week 4 | ||
Erythra | 1 (5.0) | 0 (0.0) |
Week 12 | ||
Liver dysfunction | 0 (0.0) | 1 (5.0) |
Erythra | 1 (5.0) | 1 (5.0) |
Pancreatitis | 0 (0.0) | 1 (5.0) |
Event | JieDuTongLuoShengJin granules + HCQ (%) | Placebo + HCQ (%) |
---|---|---|
Week 4 | ||
Erythra | 1 (5.0) | 0 (0.0) |
Week 12 | ||
Liver dysfunction | 0 (0.0) | 1 (5.0) |
Erythra | 1 (5.0) | 1 (5.0) |
Pancreatitis | 0 (0.0) | 1 (5.0) |